Covered Indications
Screening for organic acid disorders may be considered medically necessary when ANY of the following indications is met:
ONE of the following
The member is a newborn or infant up to 1 year of age.<= 12 months
The member has a metabolic disorder (see Billing Guidelines).
Methylmalonic acid testing is performed for suspicion of vitamin B12 deficiency.
Not Medically Necessary Testing
Organic acid testing is considered not medically necessary when the covered-indication criteria are not met, including but not limited to testing for:
Any of the following indications without a qualifying covered indication
Blood sugar dysregulation
Multiple chemical sensitivity
Multi-Analyte Organic Acid Panels
Panels that include multiple organic acids are considered not medically necessary, including but not limited to:
Any of the following multi-analyte panels
Genova Diagnostics® Metabolic Analysis Profile (Organic Acids)
Genova Diagnostics® Organix® Basic Profile
Genova Diagnostics® Organix® Comprehensive Profile
Genova Diagnostics® Organix® Dysbiosis Profile
The Great Plains Laboratory, Inc. Organic Acid Test
General Medical-Necessity Criteria
Organic acid testing is generally not medically necessary, with exceptions for newborns and patients with suspected metabolic disorders.
Testing may be considered medically necessary when ONE of the following applies
The patient is a newborn or infant up to 1 year of age.<= 12 months
The patient has a suspected metabolic disorder.
Non-Newborn Diagnosis-Code Criteria
Excluding newborns 12 months of age or younger, CPT 83918, 83919, and 83921 may be considered medically necessary only when billed with a qualifying diagnosis code.
ALL of the following
The patient is not a newborn or infant 12 months of age or younger.> 12 months
The claim includes a diagnosis code in the range E00-E89 or one of the following codes: K909, Z8639, Z13228, Z8349, or G9341.
Methylmalonic Acid Testing for Potential B12 Deficiency
CPT 83921 may be considered medically necessary for methylmalonic acid testing for potential vitamin B12 deficiency when the suspected deficiency is supported by one of the following diagnosis codes:
ONE of the following diagnosis codes
D51.0 — Vitamin B12 deficiency anemia due to intrinsic factor deficiency
D51.1 — Selective vitamin B12 malabsorption with proteinuria
D51.2 — Transcobalamin II deficiency
D51.3 — Other dietary vitamin B12 deficiency anemias
D51.8 — Other vitamin B12 deficiency anemias
For adults, an organic-acid testing claim associated only with a metabolic-disorder diagnosis is not medically necessary unless the patient is a newborn or infant up to 1 year of age or there is a suspected metabolic disorder. Clinical practice guidelines recommend organic acid testing to diagnose metabolic disorders in adults; however, well-designed clinical studies have not shown that testing improves overall health outcomes when used to diagnose metabolic disorders in adults.
When no specific CPT or HCPCS code exists for a panel, the provider must bill an unlisted code under Coding Policy 30.0. Individual tests in the panel must not be billed separately as if performed individually; doing so misrepresents the services performed and is inconsistent with CPT and CMS guidelines. CMS identified unbundling laboratory panels as an example of fraudulent billing in a Healthcare Fraud Prevention Partnership white paper published in May 2018.
Testing is not medically necessary when the member is not a newborn or infant up to 1 year of age, does not have a metabolic disorder or suspected metabolic disorder, and is not receiving methylmalonic acid testing for suspected vitamin B12 deficiency.
The following named multi-organic-acid panels are considered not medically necessary: Genova Diagnostics® Metabolic Analysis Profile (Organic Acids); Genova Diagnostics® Organix® Basic Profile; Genova Diagnostics® Organix® Comprehensive Profile; Genova Diagnostics® Organix® Dysbiosis Profile; and The Great Plains Laboratory, Inc. Organic Acid Test.
Organic acid testing is generally not medically necessary because well-designed clinical studies have not shown improvement in overall health outcomes when testing is used to diagnose metabolic disorders in adults. Testing is considered not medically necessary except for newborns and patients with suspected metabolic disorders, subject to the applicable coverage and coding criteria.
For non-newborn patients, CPT 83918 (organic acids, total, quantitative, each specimen), CPT 83919 (organic acids, qualitative, each specimen), and CPT 83921 (organic acid, single, quantitative) may be considered medically necessary only when billed with a diagnosis code in the range E00-E89 or one of the following codes: K909, Z8639, Z13228, Z8349, or G9341. When other diagnosis codes are billed, these CPT codes will deny as not medically necessary. CPT 83921 may also be considered medically necessary for methylmalonic acid testing for potential vitamin B12 deficiency when billed with D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.